Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.55 |
---|---|
High | 0.55 |
Low | 0.50 |
Bid | 0.521 |
Offer | 0.540 |
Previous close | 0.55 |
Average volume | 21.28k |
---|---|
Shares outstanding | 1.34m |
Free float | 1.24m |
P/E (TTM) | -- |
Market cap | 697.53k EUR |
EPS (TTM) | -230.10 EUR |
Data delayed at least 15 minutes, as of Sep 20 2024 16:14 BST.
More ▼
- Oxurion Share Consolidation
- Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
- Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024
- Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production
- Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024
- Oxurion Announces Extraordinary General Shareholders’ Meeting
- Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024
- Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD
More ▼